Indications
Therapeutic Asset Ratings
5,098 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Dexasone
B-Cell Adult Acute Lymphocytic Leukemia
Mayo Clinic
P3
B
(62)
Dexasone
Non-Hodgkin Lymphoma
Mwanasha Merrill, MD
P3
B
(62)
Disitamab Vedotin
Cancer
LaNova Medicines Limited
P3
B
(62)
Droxidopa
Multiple System Atrophy
Loma Linda University
P3
B
(62)
Enzalutamide
Prostate Adenocarcinoma
Prostate Cancer Clinical Trials Consortium
P3
B
(62)
Enzalutamide
Prostate Neoplasm
Qilu Pharmaceutical Co., Ltd.
P3
B
(62)
Epcoritamab
Diffuse Large B-Cell Lymphoma
Mwanasha Merrill, MD
P3
B
(62)
Epirubicin
Invasive Breast Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
P3
B
(62)
Epirubicin
Ovarian Cancer
Kalinski, Pawel, MD, PhD
P3
B
(62)
Epirubicin
Prostate Cancer
Icahn School of Medicine at Mount Sinai
P3
B
(62)
Equine Atg
Acute Myeloid Leukemia
Shanxi Bethune Hospital
P3
B
(62)
Famitinib
Non-Small Cell Lung Carcinoma
Second Affiliated Hospital of Nanchang University
P3
B
(62)
Flutemetamol
Dementia
Akiva Mintz
P3
B
(62)
Fruquintinib
Metastasis From Malignant Tumor Of Colon
Peking University
P3
B
(62)
Fulvestrant
Breast Carcinoma
IDEAYA Biosciences
P3
B
(62)
hec585
Idiopathic Pulmonary Fibrosis
Sunshine Lake Pharma Co., Ltd.
P3
B
(62)
ICP34.5-, ICP47-DELETED HERPES SIMPLEX VIRUS 1 (HSV-1) INCORPORATING THE HUMAN GM-CSF GENE
Cutaneous Melanoma
University of Louisville
P3
B
(62)
Imatinib
Adult Acute Lymphoblastic Leukemia
PETHEMA Foundation
P3
B
(62)
Imnn-001
Ovarian Carcinoma
Imunon
P3
B
(62)
Imnn-001
Primary Peritoneal Carcinoma
Imunon
P3
B
(62)
Ivonescimab
Non-Small Cell Lung Carcinoma
European Organisation for Research and Treatment of Cancer - EORTC
P3
B
(62)
Ivonescimab
Small Cell Lung Carcinoma
PrECOG, LLC.
P3
B
(62)
Ketorolac
Substance-Related Disorder
Wake Forest University Health Sciences
P3
B
(62)
Keyhole Limpet Hemocyanin
Relapsing-Remitting Multiple Sclerosis
Novartis Pharmaceuticals
P3
B
(62)
Lenalidomide
Diffuse Large B-Cell Lymphoma
Guangzhou Lupeng Pharmaceutical Company LTD.
P3
B
(62)
Showing 2451 to 2475 of 5,098 assets
Previous
Page 99 of 204
Next